Mitochondrial Mechanisms in Aging with HIV and Substance Use (R01, No Clinical Trials)
This R01 funds basic and preclinical studies to uncover how mitochondrial dysfunction links HIV infection, antiretroviral therapy, and substance use to neurocognitive decline and immune aging. The goal is to identify protective and harmful pathways, biomarkers, and targets that could lead to interventions for people aging with HIV and substance use disorders (clinical trials are not allowed).<…
Background: According to the Centers for Disease Control and Prevention, more than half of all people with human immunodeficiency virus (HIV) in the United States are age 50 or older, and thousands of older people acquire HIV every year. The lifelong consequences of living with HIV, heritage ant…
Funding Source
Awards & funding
Eligibility
Foreign Organizations: Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Eligible Individuals (PD/P…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers